On
Thursday, the Committee continued progress with its agenda, completing
deliberations on c-octaBDE, PeCB, alpha-HCH and beta-HCH.
On
Thursday, POPRC-4 considered many issues, including: conflict-of-interest
procedures; the format of recommendations for listing; draft RMEs for
commercial octabromodiphenyl ether (c-octaBDE), pentachlorobenzene (PeCB),
alpha- and beta-hexachlorocyclohexane (HCH); and the draft risk profile for
short-chained chlorinated paraffins (SCCPs).
On Friday, POPRC-4 will continue discussions on, inter alia, endosulfan, activities to enhance effective participation by parties in the work of the POPRC, toxic interactions between POPs, and adoption of the POPRC-4 report.
Comments